跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
glucokinase activator
首页
药物
glucokinase activator
glucokinase activator
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
THERAPEUTIC USES OF GLUCOKINASE ACTIVATORS IN COMBINATION WITH INSULIN OR INSULIN ANALOGS
EP 4487909 A2
申请人: VTV THERAPEUTICS LLC
优先权: 2018
CN
EP
US
9 件公开
SOLID COMPOSITIONS COMPRISING A GLUCOKINASE ACTIVATOR AND METHODS OF MAKING AND USING THE SAME
EP 2964197 A1
申请人: VTV THERAPEUTICS LLC
优先权: 2013
CN
EP
US
WO
8 件公开
Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof
US 11992477 B2
申请人: HUA MEDICINE SHANGHAI LTD
优先权: 2018
CN
US
8 件公开
Indole compound
US 8410087 B2
申请人: YASUMA TSUNEO
优先权: 2006
US
8 件公开
PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR
EP 4244221 B1
申请人: HUA MEDICINE SHANGHAI LTD
优先权: 2021
EP
US
WO
6 件公开
Activators of glucokinase
US 8940927 B2
申请人: TIAN FENG
优先权: 2007
CN
US
6 件公开
Glucokinase activator compositions for the treatment of diabetes
CN 104349790 A
申请人: TRANSTECH PHARMA LLC
优先权: 2012
CN
US
6 件公开
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
US 9359313 B2
申请人: MJALLI ADNAN M M
优先权: 2011
US
5 件公开
GLUCOKINASE ACTIVATOR FOR COGNITIVE DISORDERS AND NEURODEGENERATIVE DISEASES
EP 4725482 A1
申请人: HUA MEDICINE SHANGHAI LTD
优先权: 2023
CN
EP
US
WO
4 件公开
NOVEL CRYSTALLINE COMPOUND USEFUL AS GLK ACTIVATOR
US 2010094009 A1
申请人: MCCABE JAMES
优先权: 2006
CN
US
4 件公开
第 1 / 6 页
上一页
下一页
药物
反馈